The Other Half of the Equation: Understanding How Male Reproductive Health Shapes Fertility Outcomes

For decades, the cultural narrative around infertility has centered almost exclusively on women. Discussions about egg quality, ovarian reserve, and uterine health dominate both clinical waiting rooms and online forums, while the male contribution to conception is frequently treated as a footnote. The data, however, tells a different story.

According to the American Urological Association, male factor infertility is either the primary or a contributing cause in approximately 40 to 50 percent of all infertility cases in the United States. Yet many men enter fertility evaluations having never seriously considered that their reproductive health might warrant attention. Closing that knowledge gap is not simply a matter of fairness—it is a clinical necessity that can meaningfully alter the course and cost of treatment.

What a Semen Analysis Actually Measures

The foundational diagnostic tool for male fertility is the semen analysis, a laboratory evaluation that examines a sperm sample across several parameters. Understanding what each measurement reflects is essential for interpreting results and having informed conversations with a urologist or reproductive endocrinologist.

Concentration refers to the number of sperm cells present per milliliter of semen. The World Health Organization (WHO) defines a normal concentration as 16 million sperm per milliliter or more. Values below this threshold are classified as oligospermia; a complete absence of sperm in the ejaculate is termed azoospermia.

Motility describes the percentage of sperm that are moving, as well as the quality of that movement. Forward-progressive motility—sperm actively swimming in a directed, purposeful manner—is the category most relevant to natural fertilization. At least 30 percent of sperm should demonstrate progressive motility under WHO reference ranges.

Morphology evaluates the physical structure of sperm cells. Sperm are assessed under a microscope using standardized criteria (most commonly Kruger strict criteria) to determine what percentage have a normal head, midpiece, and tail. A morphology rate of 4 percent or higher is considered within the normal range—a figure that surprises many patients, given how low it sounds.

Volume and pH round out the standard analysis. Low semen volume can indicate ejaculatory duct obstruction or issues with the seminal vesicles, while abnormal pH may point to infection or anatomical concerns.

Common Diagnoses and What They Mean

Abnormal semen parameters are not a single diagnosis but a spectrum of conditions with distinct underlying causes.

Varicocele is the most frequently identified correctable cause of male infertility, present in approximately 35 percent of men evaluated for fertility issues. A varicocele is an enlargement of the veins within the scrotum—similar to varicose veins—that raises testicular temperature and disrupts sperm production. Surgical repair (varicocelectomy) can improve semen parameters in many cases and is often performed by a urologist specializing in male reproductive medicine.

Hormonal imbalances, including low testosterone, elevated prolactin, or thyroid dysfunction, can impair sperm production at the level of signaling between the brain and the testes. These conditions are generally identifiable through blood work and, in many cases, treatable.

Obstructive causes, such as prior vasectomy, prior infections (including chlamydia or gonorrhea), or congenital absence of the vas deferens, can result in azoospermia despite normal sperm production in the testes. Surgical sperm retrieval techniques—including testicular sperm extraction (TESE) and microsurgical epididymal sperm aspiration (MESA)—can obtain viable sperm for use in IVF with ICSI even when none is present in the ejaculate.

When Genetic Testing Becomes Relevant

For men with severely abnormal semen parameters, particularly those with very low sperm counts or azoospermia, genetic evaluation adds important clinical information.

Y-chromosome microdeletion testing identifies missing genetic material on the Y chromosome that can impair sperm production. Karyotype analysis checks for chromosomal abnormalities such as Klinefelter syndrome (47,XXY), which is present in a meaningful proportion of men with non-obstructive azoospermia. Testing for CFTR gene mutations is recommended for men with congenital bilateral absence of the vas deferens, as this condition is genetically linked to cystic fibrosis.

These results carry implications not only for treatment planning but also for the potential transmission of genetic conditions to biological children—a conversation that genetic counselors are trained to facilitate.

Lifestyle Factors That Influence Sperm Quality

Sperm production—a process called spermatogenesis—takes approximately 74 days to complete. This timeline is clinically significant because it means that lifestyle changes made today will not be reflected in a semen analysis for roughly two and a half months. It also means that environmental exposures have a meaningful window in which they can affect sperm quality.

Evidence-supported factors that men can actively modify include:

• Heat exposure: The testes function optimally at temperatures slightly below core body temperature. Frequent use of hot tubs, saunas, or laptops placed directly on the lap has been associated with reduced sperm parameters. Loose-fitting underwear may modestly reduce scrotal temperature, though the clinical significance of this change remains debated.
• Tobacco and recreational drug use: Cigarette smoking is associated with reduced sperm concentration, motility, and morphology. Cannabis use has similarly been linked to lower sperm counts and altered morphology in multiple studies.
• Alcohol consumption: Heavy alcohol use disrupts testosterone production and has been associated with lower semen volume and sperm concentration. Moderate consumption appears to carry lower risk, though some research suggests even modest intake may have effects.
• Body weight: Obesity is associated with hormonal dysregulation that can suppress sperm production. Weight loss in overweight men has been shown to improve semen parameters in some studies.
• Oxidative stress and antioxidants: Reactive oxygen species can damage sperm DNA and impair motility. Antioxidant supplementation—including coenzyme Q10, vitamin C, vitamin E, and zinc—has shown promise in clinical trials, though evidence remains mixed and supplementation should be discussed with a physician.
• Anabolic steroids: Exogenous testosterone and anabolic steroids suppress the body's natural hormone signaling, often dramatically reducing or halting sperm production. Recovery after cessation can take a year or longer and is not guaranteed.

The Male Partner's Active Role in Fertility Treatment

Male factor infertility is a shared reproductive concern, not an isolated male problem. Yet men often report feeling sidelined during fertility treatment—present at appointments but not fully integrated into the decision-making process.

Reproductive endocrinologists and urologists who specialize in male fertility can work in parallel, evaluating both partners simultaneously to identify the most efficient path forward. When sperm parameters are abnormal, the treatment approach for the couple—whether timed intercourse with intrauterine insemination (IUI) or IVF with ICSI—will depend substantially on the severity of those findings.

For couples using donor sperm or surgical sperm retrieval, the emotional dimensions of treatment are significant, and mental health support should be part of the care plan for both partners.

Reproductive medicine has advanced considerably in its ability to work with even severely compromised sperm. A single viable sperm cell, retrieved surgically if necessary, is sufficient for ICSI—a technique in which one sperm is injected directly into a mature egg. Understanding this reality helps men recognize that a difficult semen analysis result is a starting point for a conversation, not a conclusion.